Original Research
Published on 07 May 2021
Beta-Elemene Reduces the Malignancy of Non-Small Cell Lung Cancer by Enhancing C3orf21 Expression
in Cancer Molecular Targets and Therapeutics
- 2,245 views
- 8 citations
Original Research
Published on 07 May 2021
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 07 May 2021
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 06 May 2021
in Cancer Molecular Targets and Therapeutics
Systematic Review
Published on 05 May 2021
in Cancer Molecular Targets and Therapeutics
Review
Published on 03 May 2021
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 03 May 2021
in Cancer Molecular Targets and Therapeutics
Review
Published on 30 Apr 2021
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 30 Apr 2021
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 29 Apr 2021
in Cancer Molecular Targets and Therapeutics
Review
Published on 29 Apr 2021
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 28 Apr 2021
in Cancer Molecular Targets and Therapeutics
Review
Published on 26 Apr 2021
in Cancer Molecular Targets and Therapeutics
Review
Published on 23 Apr 2021
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 22 Apr 2021
in Cancer Molecular Targets and Therapeutics
Review
Published on 22 Apr 2021
in Cancer Molecular Targets and Therapeutics
Review
Published on 22 Apr 2021
in Cancer Molecular Targets and Therapeutics